🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims first to assess the efficacy, safety, and effectiveness of ...
Status
Unknown
Location
SZUMC
Start Date
2020-03-28
Trial ID
NCT05925140
This study will examine the impact of anti-programmed cell death 1 (PD1) th...
Status
Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2025-02-20
Trial ID
NCT06599619
Treatments Being Tested
Patients with infantile or late infantile NCL have either a reduced amount ...
Status
Completed
Location
Oregon Health and Science University
Start Date
2006-05
Trial ID
NCT00337636
Treatments Being Tested
For many years there is a lack of large randomized controlled trials that s...
Status
Unknown
Location
Soroka Medical Center
Start Date
2020-12
Trial ID
NCT04558268
Treatments Being Tested
The purpose of this study is to test the hypothesis that administering Thym...
Status
Withdrawn
Location
Cedars-Sinai Medical Center
Start Date
2010-11
Trial ID
NCT01157949
Treatments Being Tested
This trial proposes to evaluate the immunologic and potential clinical effe...
Status
Not Yet Recruiting
Location
UMPC Hillman Cancer Center
Start Date
2026-08
Trial ID
NCT07634094
Treatments Being Tested
This study is designed to treat systemic sclerosis (scleroderma) patients w...
Status
Terminated
Location
Northwestern University, Feinberg School of Medicine
Start Date
2018-05-17
Trial ID
NCT03593902
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
The goal of this clinical trial is to learn if peginterferon alfa-2b can re...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07120750
Treatments Being Tested
This study is a new Phase II trial to assess the toxicity and efficacy of a...
Status
Withdrawn
Location
Northwestern University
Start Date
2019-11
Trial ID
NCT04154735
Treatments Being Tested